Machine learning can be used to help clinicians with early diagnosis
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has established a blood-based test that could be used to predict the risk of Alzheimer’s disease up to 3.5 years before clinical diagnosis.
The clinical trial began in 2019 and involved 3,900 volunteers.
For chronic conditions such as rheumatoid arthritis, treatment often involves lifelong injections. Fear of needles, injection-associated infection and pain are responsible for patients skipping doses, which encourages the development of new delivery strategies that combine efficacy with limited side effects to treat patients adequately.
A quarter-sized device created at Houston Methodist could drastically alter the course of treatment for Type 1 diabetes, a chronic condition that impacts millions of Americans and does not have a cure.
13 december 2022 will go down in history as the day the Government guaranteed a healthier, smokefree future for the next generation of New Zealanders, Associate Health Minister Dr Ayesha Verrall says.